SOURCE: Mediware Information Systems
LENEXA, KS--(Marketwire - Apr 11, 2011) - Mediware Information Systems, Inc. (NASDAQ: MEDW) announced today that it has completed the acquisition of certain assets of CareCentric, Inc. The transaction adds more than 300 new customers, and the related products, services and contracts supporting home medical equipment, home health and home infusion providers throughout the United States.
Mediware's plans are to integrate the CareCentric business with its existing Alternate Care Solutions (ACS) product line that already supports almost 400 customer facilities with software targeting the specific needs of home medical equipment, home health, home infusion, specialty pharmacy and other outpatient care providers. Mediware formed ACS in March 2010 following the December 2009 acquisition of Healthcare Automation Inc. and Advantage Reimbursement Inc., and the November 2008 acquisition of Hann's On Software.
"Through Mediware's ACS product line we are dedicating business, healthcare and technology resources to develop and deliver the industry's most comprehensive software solutions," said Thomas Mann, Mediware's president and chief executive officer. "We believe this segment of healthcare shows immense promise. The nation's population continues to age and we believe the use of home and outpatient-based care will increase. Providing these services outside the hospital is more cost effective and is simply more appealing to patients. As these services expand, we believe the demand for safe and efficient care management systems will increase.
"Providers of home and alternate-site care face unique challenges that can be aided through automation and advanced technologies," continued Mr. Mann. "From patient acquisition through final reimbursement, Mediware software is positioned to ensure our customers are effective and efficient, and that they can be quickly paid for the services provided to their patients."
Mediware's Alternate Care Solutions group is led by Mr. Ken Pereira, who was formerly the CEO of Healthcare Automation. Mr. Pereira and the Mediware ACS team will be meeting with customers, prospects and partners throughout MedTrade's Spring conference, held in Las Vegas April 12-14. To schedule a meeting, please visit Mediware's website and select 'News and Events' or email email@example.com.
Mediware delivers interoperable best-of-breed software systems that improve efficiencies and address safety concerns, enabling healthcare organizations to improve care processes while decreasing costs. Core Mediware solutions include blood management technologies for hospitals and blood centers; medication management solutions for hospitals, behavioral health facilities, infusion and specialty pharmacy providers; and business intelligence-based performance management solutions for clinical, regulatory and financial aspects of the broader healthcare market. For more information about Mediware products and services, visit our website at www.mediware.com.
Certain statements in this press release may constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the "Act") and are intended to be covered by the safe harbor created thereby. Such forward-looking statements are not necessarily based on historical facts and involve known and unknown risks, uncertainties and other factors which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward looking statements. These risk and uncertainties include but are not limited to those disclosed in the Company's Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company does not intend to, and undertakes no obligation to, update forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results, financial condition or business over time. The Company regularly posts important information to the investor relations section of its website.